[HTML][HTML] Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled …

SB Sirima, A Ouedraogo, N Barry, M Siribie… - International Journal of …, 2021 - Elsevier
Abstract Objectives In 2017, the World Health Organisation (WHO) pre-qualified a single-
dose typhoid conjugate vaccine (TCV) and identified TCV co-administration studies as a …

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.

SB Sirima, A Ouedraogo, N Barry, M Siribie… - … Journal of Infectious …, 2021 - europepmc.org
Objectives In 2017, the World Health Organisation (WHO) pre-qualified a single-dose
typhoid conjugate vaccine (TCV) and identified TCV co-administration studies as a research …

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial

SB Sirima, A Ouedraogo, N Barry, M Siribie… - International Journal of …, 2021 - ijidonline.com
Abstract Objectives In 2017, the World Health Organisation (WHO) pre-qualified a single-
dose typhoid conjugate vaccine (TCV) and identified TCV co-administration studies as a …

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial

SB Sirima, A Ouedraogo, N Barry… - … publication of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives In 2017, the World Health Organisation (WHO) pre-qualified a single-dose
typhoid conjugate vaccine (TCV) and identified TCV co-administration studies as a research …

[HTML][HTML] Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled …

SB Sirima, A Ouedraogo, N Barry, M Siribie… - … Journal of Infectious …, 2021 - ncbi.nlm.nih.gov
ABSTRACT Objectives: In 2017, the World Health Organisation (WHO) pre-qualified a single-
dose typhoid conjugate vaccine (TCV) and identified TCV co-administration studies as a …